{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Corona virus disease 2019", "Mechanisms", "Polysaccharides", "Pulmonary fibrosis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "32829859", "DateCompleted": {"Year": "2020", "Month": "09", "Day": "04"}, "DateRevised": {"Year": "2023", "Month": "03", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "07", "Day": "07"}], "Language": ["eng"], "ELocationID": ["10.1016/j.carbpol.2020.116740", "S0144-8617(20)30913-9"], "Journal": {"ISSN": "1879-1344", "JournalIssue": {"Volume": "247", "PubDate": {"Year": "2020", "Month": "Nov", "Day": "01"}}, "Title": "Carbohydrate polymers", "ISOAbbreviation": "Carbohydr Polym"}, "ArticleTitle": "A review for natural polysaccharides with anti-pulmonary fibrosis properties, which may benefit to patients infected by 2019-nCoV.", "Pagination": {"StartPage": "116740", "MedlinePgn": "116740"}, "Abstract": {"AbstractText": ["Pulmonary fibrosis (PF) is a lung disease with highly heterogeneous and mortality rate, but its therapeutic options are now still limited. Corona virus disease 2019 (COVID-19) has been characterized by WHO as a pandemic, and the global number of confirmed COVID-19 cases has been more than 8.0 million. It is strongly supported for that PF should be one of the major complications in COVID-19 patients by the evidences of epidemiology, viral immunology and current clinical researches. The anti-PF properties of naturally occurring polysaccharides have attracted increasing attention in last two decades, but is still lack of a comprehensively understanding. In present review, the resources, structural features, anti-PF activities, and underlying mechanisms of these polysaccharides are summarized and analyzed, which was expected to provide a scientific evidence supporting the application of polysaccharides for preventing or treating PF in COVID-19 patients."], "CopyrightInformation": "Copyright \u00a9 2020 Elsevier Ltd. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangdong Key Lab of Sugarcane Improvement & Bio-Refinery, Guangdong Bioengineering Institute (Guangzhou Sugarcane Industry Research Institute), Guangdong Academy of Sciences, Guangzhou, 510316, People's Republic of China."}], "LastName": "Chen", "ForeName": "Rui-Rong", "Initials": "RR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangdong Key Lab of Sugarcane Improvement & Bio-Refinery, Guangdong Bioengineering Institute (Guangzhou Sugarcane Industry Research Institute), Guangdong Academy of Sciences, Guangzhou, 510316, People's Republic of China."}], "LastName": "Li", "ForeName": "Ya-Jun", "Initials": "YJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangdong Key Lab of Sugarcane Improvement & Bio-Refinery, Guangdong Bioengineering Institute (Guangzhou Sugarcane Industry Research Institute), Guangdong Academy of Sciences, Guangzhou, 510316, People's Republic of China. Electronic address: gzcsircjj@163.com."}], "LastName": "Chen", "ForeName": "Jun-Jia", "Initials": "JJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangdong Key Lab of Sugarcane Improvement & Bio-Refinery, Guangdong Bioengineering Institute (Guangzhou Sugarcane Industry Research Institute), Guangdong Academy of Sciences, Guangzhou, 510316, People's Republic of China. Electronic address: luyixiao-0707@163.com."}], "LastName": "Lu", "ForeName": "Chuan-Li", "Initials": "CL"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Carbohydr Polym", "NlmUniqueID": "8307156", "ISSNLinking": "0144-8617"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "DANCR long noncoding RNA, human"}, {"RegistryNumber": "0", "NameOfSubstance": "FOXO3 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Forkhead Box Protein O3"}, {"RegistryNumber": "0", "NameOfSubstance": "HNRNPD protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Heterogeneous Nuclear Ribonucleoprotein D0"}, {"RegistryNumber": "0", "NameOfSubstance": "Polysaccharides"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Long Noncoding"}, {"RegistryNumber": "0", "NameOfSubstance": "SMAD2 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "SMAD3 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Smad2 Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "Smad3 Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "Transforming Growth Factor beta1"}, {"RegistryNumber": "11056-06-7", "NameOfSubstance": "Bleomycin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antioxidants"}, {"QualifierName": [], "DescriptorName": "Betacoronavirus"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Biological Products"}, {"QualifierName": ["toxicity"], "DescriptorName": "Bleomycin"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": ["complications"], "DescriptorName": "Coronavirus Infections"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": ["physiology"], "DescriptorName": "Forkhead Box Protein O3"}, {"QualifierName": ["chemistry"], "DescriptorName": "Fungi"}, {"QualifierName": ["physiology"], "DescriptorName": "Heterogeneous Nuclear Ribonucleoprotein D0"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Macrophages"}, {"QualifierName": [], "DescriptorName": "Medicine, Chinese Traditional"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["drug effects"], "DescriptorName": "Neutrophils"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["complications"], "DescriptorName": "Pneumonia, Viral"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Polysaccharides"}, {"QualifierName": ["chemically induced", "drug therapy", "etiology", "prevention & control"], "DescriptorName": "Pulmonary Fibrosis"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "RNA, Long Noncoding"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["chemistry"], "DescriptorName": "Seaweed"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["physiology"], "DescriptorName": "Smad2 Protein"}, {"QualifierName": ["physiology"], "DescriptorName": "Smad3 Protein"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Transforming Growth Factor beta1"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ahn J.Y., Kim M.H., Lim M.J., Park S., Lee S.L.O., Yun Y.S., Song J.Y. The inhibitory effect of Ginsan on TGF-beta mediated fibrotic process. Journal of Cellular Physiology. 2011;226(5):1241\u20131247.", "ArticleIdList": ["20945375"]}, {"Citation": "Bale S., Venkatesh P., Sunkoju M., Godugu C. An adaptogen: Withaferin A ameliorates in vitro and in vivo pulmonary fibrosis by modulating the interplay of fibrotic, matricelluar proteins, and cytokines. Frontiers in Pharmacology. 2018;9", "ArticleIdList": ["PMC5874319", "29623041"]}, {"Citation": "Bickerman H.A., Beck G.J., Barach A.L. The use of prednisone (Meticorten) in respiratory disease. II. Pulmonary emphysema and pulmonary fibrosis. Journal of Chronic Diseases. 1955;2(3):247\u2013259.", "ArticleIdList": ["13252068"]}, {"Citation": "Cai Z.N., Li W., Mehmood S., Pan W.J., Wang Y., Meng F.J.\u2026Chen Y. Structural characterization, in vitro and in vivo antioxidant activities of a heteropolysaccharide from the fruiting bodies of Morchella esculenta. Carbohydrate Polymers. 2018;195:29\u201338.", "ArticleIdList": ["29804979"]}, {"Citation": "Cameli P., Carleo A., Bergantini L., Landi C., Prasse A., Bargagli E. Oxidant/antioxidant disequilibrium in idiopathic pulmonary fibrosis pathogenesis. Inflammation. 2020;43(1):1\u20137.", "ArticleIdList": ["31297749"]}, {"Citation": "Canestaro W.J., Forrester S.H., Raghu G., Ho L., Devine B.E. Drug treatment of idiopathic pulmonary fibrosis systematic review and network meta-analysis. Chest. 2016;149(3):756\u2013766.", "ArticleIdList": ["26836914"]}, {"Citation": "Chen J.H., Lu J.H., Wang B.L., Zhang X.L., Huang Q.Y., Yuan J.\u2026Chu H.Q. Polysaccharides from Dendrobium officinale inhibit bleomycin-induced pulmonary fibrosis via the TGF beta 1-Smad2/3 axis. International Journal of Biological Macromolecules. 2018;118:2163\u20132175.", "ArticleIdList": ["30030077"]}, {"Citation": "Chen J.H., Shi Y.Y., He L., Hao H.R., Wang B.L., Zheng Y.L., Hu C.P. Protective roles of polysaccharides from Ganoderma lucidum on bleomycin-induced pulmonary fibrosis in rats. International Journal of Biological Macromolecules. 2016;92:278\u2013281.", "ArticleIdList": ["27381587"]}, {"Citation": "Cho Y.J., Son H.J., Kim K.S. A 14-week randomized, placebo-controlled, double-blind clinic trail to evaluate the efficacy and safety of gineng polysaccharide (Y-75) Journal of Translational Medicine. 2014;12", "ArticleIdList": ["PMC4196019", "25297058"]}, {"Citation": "Cui C., Lu J.H., Sun-Waterhouse D.X., Mu L.X., Sun W.Z., Zhao M.M., Zhao H.F. Polysaccharides from Laminaria japonica: Structural characteristics and antioxidant activity. Lwt-Food Science and Technology. 2016;73:602\u2013608."}, {"Citation": "Gao Y. JiLin Agricultural University; 2016. Study on Gua Lou Xie Bai decoction for inhibiting pulmonary fibrosis. (Thesis)"}, {"Citation": "Guo Q., Meng Y., Zhao Y., Cheng X.C., Lu Y.X., Zhang Q.L. Inhibitory effect of Bletilla striata extracts on bleomycin-induced pulmonary fibrosis in rats. Journal of International Pharmaceutical Research. 2016;43(3):518\u2013523."}, {"Citation": "Han L.P., Liang Z.Y., Zhang L.P., Han L.M., Gong R.C., Ma X.H. Purification and composition analysis of a polysaccharide RSA from Rhodiola sachalinensis A. Bor. Chinese Pharmaceutical Journal. 2002;37(6):418\u2013421."}, {"Citation": "He T.B., Huang Y.P., Yang L., Liu T.T., Gong W.Y., Wang X.J.\u2026\u2026Hu J.M. Structural characterization and immunomodulating activity ofpolysaccharide from Dendrobium officinale. International Journal of Biological Macromolecules. 2016;83:34\u201341.", "ArticleIdList": ["26592697"]}, {"Citation": "He X.R., Wang X.X., Fang J.C., Zhao Z.F., Huang L.H., Guo H., Zheng X.H. Bletilla striata: Medicinal uses, phytochemistry and pharmacological activities. Journal of Ethnopharmacology. 2017;195:20\u201338.", "ArticleIdList": ["27865796"]}, {"Citation": "Hoffman M., Jia Z.H., Pena M.J., Cash M., Harper A., Blackburn A.R.\u2026York W.S. Structural analysis of xyloglucans in the primary cell walls of plants in the subclass Asteridae. Carbohydrate Research. 2005;340(11):1826\u20131840.", "ArticleIdList": ["15975566"]}, {"Citation": "Hu R., Yang Y., Bai H.B., Fu X.C. Effect of Cordyceps polysaccharide on pingyangmycin induced pulmonary fibrosis in mice. Chinese Journal of Modern Applied Pharmacy. 2019;36(13):1639\u20131642."}, {"Citation": "Hui D.S., Wong K.T., Ko F.W., Tam L.S., Chan D.P., Woo J., Sung J.J.Y. The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest. 2005;128(4):2247\u20132261.", "ArticleIdList": ["PMC7094276", "16236881"]}, {"Citation": "Hui H.P., Li X.Z., Jin H., Yang X.Y., Xin A.Y., Zhao R.M., Qin B. Structural characterization, antioxidant and antibacterial activities of two heteropolysaccharides purified from bulbs of Lilium davidii var. unicolor Cotton. International Journal of Biological Macromolecules. 2019;133:306\u2013315.", "ArticleIdList": ["30986468"]}, {"Citation": "Hwang P.A., Yan M.D., Lin H.T.V., Li K.L., Lin Y.C. Toxicological evaluation of low molecular weight fucoidan in vitro and in vivo. Marine Drugs. 2016;14(7)", "ArticleIdList": ["PMC4962011", "27347980"]}, {"Citation": "Jacob J., Bartholmai B.J., Rajagopalan S., Karwoski R., Nair A., Walsh S.L.F.\u2026Wells A.U. Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema. Respirology. 2018;23(6):593\u2013599.", "ArticleIdList": ["29237236"]}, {"Citation": "Jiang H.D. Ocean University of China; 2008. The effects and mechanism study of TCM-based Fei KangLing (FKL) on pulmonary interstital fibrosis. (PhD thesis)"}, {"Citation": "Jiang H.D., Guan H.S. MS80, a novel sulfated oligosaccharide, inhibits pulmonary fibrosis by targeting TGF-beta 1 both in vitro and in vivo. Acta Pharmacologica Sinica. 2009;30(7):973\u2013979.", "ArticleIdList": ["PMC4006651", "19543300"]}, {"Citation": "Jin M.L., Zhao K., Huang Q.S., Xu C.L., Shang P. Isolation, structure and bioactivities of the polysaccharides from Angelica sinensis (Oliv.) Diels: A review. Carbohydrate Polymers. 2012;89(3):713\u2013722.", "ArticleIdList": ["24750855"]}, {"Citation": "Kidd P.M. The use of mushroom glucans and proteoglycans in cancer treatment. Alternative Medicine Review. 2000;5(1):4\u201327.", "ArticleIdList": ["10696116"]}, {"Citation": "Lee Y.S., Chung I.S., Lee I.R., Kim K.H., Hong W.S., Yun Y.S. Activation of multiple effector pathway of immune system by the antineoplastic immunostimulator acidic polysaccharide ginsan isolated from Panax ginseng. Anticancer Research. 1997;17(1A):323\u2013331.", "ArticleIdList": ["9066672"]}, {"Citation": "Lei F.F., Zhao J.X., Wang X.X., Yao B.T., Ding K. An experimental observation of pulmonary fibrosis in rats and its transforming growth factor beta1 treated by total hedysarum polybotyssaccharide. Journal of Chinese Medicinal Materials. 2008;31(6):873\u2013877.", "ArticleIdList": ["18998573"]}, {"Citation": "Li J., Zhang Y., Liu Y.Q., Li J.T., Wei S.C., Su W., Nie L. Effects of Astragalus polysaccharides on level of cytokines and pathological structure of lung tissue in rat model of pulmoanry fibrosis. Lishizhen Medicine and Materia Medica Research. 2011;22(7):1684\u20131685."}, {"Citation": "Li W., Cai Z.N., Mehmood S., Wang Y., Pan W.J., Zhang W.N.\u2026Chen Y. Polysaccharide FMP-1 from Morchella esculenta attenuates cellular oxidative damage in human alveolar epithelial A549 cells through PI3K/AKT/Nrf2/HO-1 pathway. International Journal of Biological Macromolecules. 2018;120:865\u2013875.", "ArticleIdList": ["30171960"]}, {"Citation": "Li Z.L., Gao Y., Zhao L., Hong B. Study on rhodiola polysaccharide against pulmonary fibrosis. Journal of Molecular Science. 2016;32(1):34\u201339."}, {"Citation": "Liu Y., Lu F., Kang L.R., Wang Z.H., Wang Y.F. Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium. BMC Pulmonary Medicine. 2017;17", "ArticleIdList": ["PMC5395978", "28420366"]}, {"Citation": "Luo Y.A., An F.Y., Li N.L., Liu Y.Q., Li C.H., Zhang Y.H., Chen J. Effects of Angelica polysaccharides and angelica small molecules on expression of \u03b1-SMA, CTGF in human embryonic lung fibroblast cells induced by TGF-\u03b21. Pharmacology and Clinics of Chinese Materia Medica. 2017;33(3):73\u201378."}, {"Citation": "Luo Y.L., Wang Y.L., Pan Z., Li N.L., Li Y., Yan X., Zhang L. Effect of lily polysaccharides combined with BMSCs transplantation on expression of TNF-alpha and NF-kappaB in bleomycin-induced pulmonary fibrosis mice. Journal of Third Military Medical University. 2013;35(5):431\u2013434."}, {"Citation": "Martinez F.J., Collard H.R., Pardo A., Raghu G., Richeldi L., Selman M.\u2026Wells A.U. Idiopathic pulmonary fibrosis. Nature Reviews Disease Primers. 2017;3", "ArticleIdList": ["29052582"]}, {"Citation": "Miniati I., Cerinic M.M. Pulmonary fibrosis in systemic sclerosis: Is treatment with cyclophosphamide more effective than placebo? Nature Clinical Practice Rheumatology. 2007;3(7):372\u2013373.", "ArticleIdList": ["17519917"]}, {"Citation": "Muhama I.I., Zulkifli N., Selvakumaran S.A.P., Lazim N.A.M. Bioactive algal-derived polysaccharides: Multi-functionalization, therapeutic potential and biomedical applications. Current Pharmaceutical Design. 2019;25(11):1147\u20131162.", "ArticleIdList": ["31258069"]}, {"Citation": "Ozaki T., Nakayama T., Ishimi H., Kawano T., Yasuoka S., Tsubura E. Glucocorticoid receptors in bronchoalveolar cells from patients with idiopathic pulmonary fibrosis. The American Review of Respiratory Disease. 1982;126(6):968\u2013971.", "ArticleIdList": ["7181237"]}, {"Citation": "Pan D., Wang L.Q., Chen C.H., Teng B.S., Wang C.D., Xu Z.X.\u2026Zhou P. Structure characterization of a novel neutral polysaccharide isolated from Ganoderma lucidum fruiting bodies. Food Chemistry. 2012;135(3):1097\u20131103.", "ArticleIdList": ["22953830"]}, {"Citation": "Qian W.B., Cai X.R., Qian Q.H., Wang D.L., Zhang L. Angelica Sinensis polysaccharide suppresses epithelial-mesenchymal transition and pulmonary fibrosis via a DANCR/AUF-1/FOXO3 regulatory axis. Aging and Disease. 2020;11(1):17\u201330.", "ArticleIdList": ["PMC6961774", "32010478"]}, {"Citation": "Qiang Z.Z., Wang Y., Li S., Wang M.W., Li C.Y. Structure and activity of Hedysari radix polysaccharides and its derivatives. Chinese Journal New Drugs. 2018;27(19):2271\u20132280."}, {"Citation": "Raghu G., Rochwerg B., Zhang Y., Garcia C.A.C., Azuma A., Behr J.\u2026Schunemann H.J. An official ATS/ERS/JRS/ALAT clinical practice guideline: Treatment of idiopathic pulmonary fibrosis an update of the 2011 clinical practice guideline. American Journal of Respiratory and Critical Care Medicine. 2015;192(2):E3\u2013E19.", "ArticleIdList": ["26177183"]}, {"Citation": "Raimundo K., Chang E., Broder M.S., Alexander K., Zazzali J., Swigris J.J. Clinical and economic burden of idiopathic pulmonary fibrosis: A retrospective cohort study. BMC Pulmonary Medicine. 2016:16.", "ArticleIdList": ["PMC4702364", "26732054"]}, {"Citation": "Richeldi L., Collard H.R., Jones M.G. Idiopathic pulmonary fibrosis. Lancet. 2017;389(10082):1941\u20131952.", "ArticleIdList": ["28365056"]}, {"Citation": "Shi L. Bioactivities, isolation and purification methods of polysaccharides from natural products: A review. International Journal of Biological Macromolecules. 2016;92:37\u201348.", "ArticleIdList": ["PMC7124366", "27377457"]}, {"Citation": "Su Y., Zhang Y., Li J., Li X.Y., Liu Y.Q., Lin X.Y., Li J.T. Effects of active ingredients in Radix hedysari on collagen area, hyaluronic acid and laminin of lung tissues in rats with pulmonary interstitial fibrosis. Chinese Journal of Information on Traditional Chinese Medicine. 2016;23(4):72\u201376."}, {"Citation": "Sun Y.X. Structure and biological activities of the polysaccharides from the leaves, roots and fruits of Panax ginseng CA Meyer: An overview. Carbohydrate Polymers. 2011;85(3):490\u2013499."}, {"Citation": "Venkataraman T., Frieman M.B. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Antiviral Research. 2017;143:142\u2013150.", "ArticleIdList": ["PMC5507769", "28390872"]}, {"Citation": "Walton K.L., Johnson K.E., Harrison C.A. Targeting TGF-beta mediated SMAD signaling for the prevention of fibrosis. Frontiers in Pharmacology. 2017;8", "ArticleIdList": ["PMC5509761", "28769795"]}, {"Citation": "Wang J., Wang B.J., Yang J.C., Wang M.Y., Chen C., Luo G.X., He W.F. Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures. Chinese Journal of Burns. 2020;36(0)", "ArticleIdList": ["32174095"]}, {"Citation": "Wang J., Geng L.H., Yue Y., Zhang Q.B. In: Zhang, editor. Vol. 163. 2019. Use of fucoidan to treat renal diseases: A review of 15 years of clinic studies; pp. 95\u2013111. (Glycans and glycosaminoglycans as clinical biomarkers and therapeutics, Pt B).", "ArticleIdList": ["31030763"]}, {"Citation": "Wang L., Zhang P., Li X.P., Zhang Y., Zhan Q.Y., Wang C. Low-molecular-weight fucoidan attenuates bleomycin-induced pulmonary fibrosis: Possible role in inhibiting TGF-beta 1-induced epithelial-mesenchymal transition through ERK pathway. American Journal of Translational Research. 2019;11(4):2590\u20132602.", "ArticleIdList": ["PMC6511757", "31105865"]}, {"Citation": "Xie L.X., Liu Y.N., Fan B.X., Xiao Y.Y., Tian Q., Chen L.G.\u2026Chen W.J. Dynamic changes of serum SARS-coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge. Respiratory Research. 2005;6(3\u20135)", "ArticleIdList": ["PMC545044", "15638943"]}, {"Citation": "Xu L., Li L.C., Zhao P., Qi L.W., Li P., Gao J., Fei G.H. Total polysaccharide of Yu Ping Feng protects against bleomycin-induced pulmonary fibrosis via inhibiting transforming growth factor-beta 1-mediated type I collagen abnormal deposition in rats. The Journal of Pharmacy and Pharmacology. 2014;66(12):1786\u20131795.", "ArticleIdList": ["25209833"]}, {"Citation": "Xu Y.H., Dong J.H., An W.M., Lv X.Y., Yin X.P., Zhang J.Z.\u2026Gao B.L. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. The Journal of Infection. 2020;80(4):394\u2013400.", "ArticleIdList": ["PMC7102535", "32109443"]}, {"Citation": "Yan D.D., Tian J.Z., Zhang D., Hou L., Li L., Zhang C.H.\u2026Zhu Q.J. Inhibitory effect of Basil polysaccharide on TGF-beta-induced epithelial-mesenchymal transition of A549 cells. Traditional Chinese Drug Research and Clinical Plarmacology. 2017;28(2):154\u2013159."}, {"Citation": "Yang J.X., Sun Y., Gao L., Meng Q., Yang B.Y. Long non-coding RNA DANCR facilitates glioma malignancy by sponging miR-33a-5p. Neoplasma. 2018;65(5):790\u2013798.", "ArticleIdList": ["29940760"]}, {"Citation": "Yin J.Y., Chan B.C.L., Yu H., Lau L.Y.K., Han X.Q., Cheng S.W.\u2026Han Q.B. Separation, structure characterization, conformation and immunomodulating effect of a hyperbranched heteroglycan from Radix astragali. Carbohydrate Polymers. 2012;87(1):667\u2013675.", "ArticleIdList": ["34663019"]}, {"Citation": "Yu H.H., Ko E.C., Chang C.L., Yuan K.S.P., Wu A.T.H., Shan Y.S., Wu S.Y. Fucoidan inhibits radiation-Induced pneumonitis and lung fibrosis by reducing inflammatory cytokine expression in lung tissues. Marine Drugs. 2018;16(10)", "ArticleIdList": ["PMC6213111", "30347679"]}, {"Citation": "Zhan Y.F., An X.N., Wang S., Sun M.J., Zhou H.M. Basil polysaccharides: A review on extraction, bioactivities and pharmacological applications. Bioorganic & Medicinal Chemistry. 2020;28(1):115179.", "ArticleIdList": ["31740199"]}, {"Citation": "Zheng C., Li Y.S., Liu H.B., Yuan D., Lu B.R. Sulfoglycolipid from the marine brown alga Sargassum hemiphyllum. Journal of Asian Natural Products Research. 2001;3(2):117\u2013122.", "ArticleIdList": ["11407810"]}, {"Citation": "Zhou S.B., Zhou Y.C., Yu J.J., Du Y.X., Tan Y., Ke Y.M.\u2026Ge F. Ophiocordyceps lanpingensis polysaccharides attenuate pulmonary fibrosis in mice. Biomedecine & Pharmacotherapy. 2020;126", "ArticleIdList": ["32145591"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "4", "Day": "22"}, {"Year": "2020", "Month": "6", "Day": "19"}, {"Year": "2020", "Month": "7", "Day": "4"}, {"Year": "2020", "Month": "8", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "7"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32829859", "PMC7340049", "10.1016/j.carbpol.2020.116740", "S0144-8617(20)30913-9"]}}], "PubmedBookArticle": []}